CD 130 Pill - brown capsule/oblong, 19mm
Pill with imprint CD 130 is Brown, Capsule/Oblong and has been identified as Ranitidine Hydrochloride 300 mg. It is supplied by Dr. Reddy’s Laboratories Inc.
Ranitidine is used in the treatment of GERD; Erosive Esophagitis; Gastric Ulcer Maintenance Treatment; Duodenal Ulcer Prophylaxis; Cutaneous Mastocytosis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for CD 130
Ranitidine Hydrochloride
- Imprint
- CD 130
- Strength
- 300 mg
- Color
- Brown
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Rx and/or OTC
- Drug Class
- H2 antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Dr. Reddy’s Laboratories Inc.
- Inactive Ingredients
-
magnesium stearate,
microcrystalline cellulose,
sodium starch glycolate type A potato,
ferrosoferric oxide,
ferric oxide red,
ferric oxide yellow,
titanium dioxide,
gelatin
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 42291-0736 (Discontinued) | AvKare, Inc. |
| 55111-0130 (Discontinued) | Dr. Reddy's Laboratories, Inc. |
Related images for "CD 130"
More about ranitidine
- Check interactions
- Compare alternatives
- Reviews (163)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: H2 antagonists
- Breastfeeding
Patient resources
Other brands
Professional resources
- Ranitidine prescribing information
- Ranitidine Capsule (FDA)
- Ranitidine Injection (FDA)
- Ranitidine Syrup (FDA)
- Ranitidine Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.